Alcoholic hepatitis

Area of Science:

• Hepatology
• Gastroenterology
• Transplantation Medicine

Background:

• Alcoholic hepatitis (AH) is a severe liver condition linked to prolonged alcohol misuse.
• Severe acute AH (AAH) carries a high mortality rate (40-60% within six months).
• Current treatments include glucocorticoids for patients with Maddrey's Discriminant Function score > 32.

Purpose of the Study:

• To evaluate the role of liver transplantation (LT) in severe alcoholic hepatitis (AH).
• To challenge the strict 6-month abstinence requirement for LT in eligible severe AAH patients.
• To improve survival rates for patients with severe AAH who do not respond to initial therapies.

Main Methods:

• Review of current treatment guidelines for severe alcoholic hepatitis.
• Analysis of prognostic factors and outcomes for patients with severe AAH.
• Discussion of contraindications and eligibility criteria for liver transplantation in AH.

Main Results:

• Severe AAH patients often have a poor prognosis, with high short-term mortality.
• Glucocorticoids are standard treatment, but many patients do not respond.
• Liver transplantation is an option for non-responders, but the 6-month abstinence rule limits its use.

Conclusions:

• The mandatory 6-month pre-transplant abstinence period for liver transplantation in severe AH may be too restrictive.
• For carefully selected severe AAH patients with adequate social support and no psychiatric issues, LT should be considered without this waiting period.
• Revising LT criteria could save lives in this high-risk patient population.